HS Pharmaceuticals, LLC HS Pharma, LLC is an early stage, privately-held and managed, research and development company focused on developing novel Silicate-based immunotherapeutics for oncology and complex/infected wound applications. HS Pharma aims to maximize global patient benefit along with shareholder value through the initial clinical development and licensing of its novel silicate-based nanoparticle drug, HS-7. […]![]()
